Search results
Moderna (MRNA) COVID-Flu Combo Jab Meets Late-Stage Study Goal
Zacks via Yahoo Finance· 3 days agoData from a late-stage study shows that Moderna's (MRNA) experimental COVID-19-influenza combination...
Two shots in one? Moderna's COVID-19 and flu vaccine reports favorable results
USA Today· 4 days agoModerna said Monday that its combination vaccine against flu andCOVID-19 drew a greater immune...
Moderna Seeks FDA Approval For Updated COVID-19 Shot For Upcoming Season
Benzinga via AOL· 6 days agoOn Friday, Moderna Inc. (NASDAQ:MRNA) announced that it has submitted an FDA application for review...
Moderna sees positive results in COVID-flu vaccine trial
The Hill via Yahoo News· 4 days agoModerna’s late-stage trial for its COVID-flu combination vaccine yielded positive results, the...
COVID-flu combo vaccine shows ‘positive’ results in phase 3 trials, Moderna says: A 'two-for' option
Fox News· 3 days agoA combination COVID-influenza vaccine is apparently one step closer to hitting the market. Moderna,...
Combined flu and Covid vaccine from Moderna shows positive trial results
PA Media: Science via Yahoo News· 4 days agoDr Philip Cruz, UK medical director at Moderna, said: “The phase three trial results for mRNA-1083,...
2-in-1 shot for flu and COVID shows promise in advanced trial
Live Science via Yahoo News· 3 days agoThe new vaccine builds upon the Nobel Prize-winning technology used to develop the first COVID-19...
Feeling rough after your COVID shot? That's a sign it's working
Medical Xpress· 3 days agoFewer than 1 in 4 people in the United States have received last year's updated COVID-19 vaccine, despite a death toll of more than 23,000 Americans this ...
Should You Pick Moderna Stock At $150 After 25% Gains In A Month?
Forbes· 7 days agoThe stock price of Moderna has seen a sharp 27% rise in a month, while its peer – BioNTech – has...
Moderna director Afeyan sells over $30 million in company stock By Investing.com
Investing.com· 2 days agoModerna , Inc. (NASDAQ:MRNA) Director Noubar Afeyan has sold a significant number of company shares,...